Drug treatment of inborn errors of metabolism: a systematic review

Alfadhel, Majid; Al-Thihli, Khalid; Moubayed, Hiba; Eyaid, Wafaa; Al-Jeraisy, Majed
June 2013
Archives of Disease in Childhood;Jun2013, Vol. 98 Issue 6, p454
Academic Journal
Background The treatment of inborn errors of metabolism (IEM) has seen significant advances over the last decade. Many medicines have been developed and the survival rates of some patients with IEM have improved. Dosages of drugs used for the treatment of various IEM can be obtained from a range of sources but tend to vary among these sources. Moreover, the published dosages are not usually supported by the level of existing evidence, and they are commonly based on personal experience. Methods A literature search was conducted to identify key material published in English in relation to the dosages of medicines used for specific IEM. Textbooks, peer reviewed articles, papers and other journal items were identified. The PubMed and Embase databases were searched for material published since 1947 and 1974, respectively. The medications found and their respective dosages were graded according to their level of evidence, using the grading system of the Oxford Centre for Evidence-Based Medicine. Results 83 medicines used in various IEM were identified. The dosages of 17 medications (21%) had grade 1 level of evidence, 61 (74%) had grade 4, two medications were in level 2 and 3 respectively, and three had grade 5. Conclusions To the best of our knowledge, this is the first review to address this matter and the authors hope that it will serve as a quickly accessible reference for medications used in this important clinical field.


Related Articles

  • The impact of improved neonatal intensive care facilities on referral pattern and outcome at a teaching hospital in Ghana. Enweronu-Laryea, C C; Nkyekyer, K; Rodrigues, O P // Journal of Perinatology;Aug2008, Vol. 28 Issue 8, p561 

    Objective:Evaluate the impact of improved neonatal intensive care facilities on survival and referral patterns at a teaching hospital in Ghana.Study Design:Retrospective cohort comparing birth weight-specific survival and referral pattern of newborns requiring intensive care before and after...

  • Mortality reduced by evidence-based therapy use in STEMI.  // PharmacoEconomics & Outcomes News;5/14/2011, Issue 628, p6 

    The article discusses a research on the link between evidence-based therapy use and survival for patients with ST-elevation myocardial infarction, which was published in the April 27, 2011 issue of the "JAMA: The Journal of the American Medical Association."

  • CLINICAL CLIPS. Russell, John J.; Beck, Jonathan D.; Mintz, Matthew // Patient Care for the Nurse Practitioner;Jun2007, Vol. 10 Issue 6, p1 

    The article presents abstracts of reports and studies from evidence-based medical literature as well as commentary relevant to primary care. They include "Meta-Analysis: Chondroitin for Osteoarthritis of the Knee or Hip" and "Influenza and COPD Mortality Protection as Pleiotropic, Dose-Dependent...

  • The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. Liberati, Alessandro; Altman, Douglas G.; Tetzlaff, Jennifer; Mulrow, Cynthia; Gøtzsche, Peter C.; Ioannidis, John P. A.; Clarke, Mike; Devereaux, P. J.; Kleijnen, Jos; Moher, David // PLoS Clinical Trials;Jul2009, Vol. 6 Issue 7, Special section p1 

    Systematic reviews and meta-analyses are essential to summarize evidence relating to efficacy and safety of health care interventions accurately and reliably. The clarity and transparency of these reports, however, is not optimal. Poor reporting of systematic reviews diminishes their value to...

  • The man who would prove all studies wrong. Giles, Jim // New Scientist;2/16/2008, Vol. 197 Issue 2643, p44 

    An interview with clinical epidemiologist John Ioannidis is presented. He discusses his introduction to cumulative meta-analysis in evidence-based medicine. He describes the method behind his paper "Why Most Published Research Findings are False." He suggests that clinical trials ought to be...

  • Meta-analiz ve Kanıta Dayalı Tıp'taki Yeri. Açıkel, Cengizhan // Klinik Psikofarmakoloji Bulteni;Jun2009, Vol. 19 Issue 2, p164 

    Meta-analysis is a very important knowledge source for evidence based medicine. Scottish Intercollegiate Guidelines Network (SIGN) accepts it as the strongest level of evidence. Briefly, it could be described, as "The statistical analysis of a large collection of study results for the purpose of...

  • Epidemiology and Reporting Characteristics of Systematic Reviews. Moher, David; Tetzlaff, Jennifer; Tricco, Andrea C.; Sampson, Margaret; Altman, Douglas G. // PLoS Medicine;Mar2007, Vol. 4 Issue 3, p0447 

    Background Systematic reviews (SRs) have become increasingly popular to a wide range of stakeholders. We set out to capture a representative cross-sectional sample of published SRs and examine them in terms of a broad range of epidemiological, descriptive, and reporting characteristics,...

  • Everything You Ever Wanted to Know About Evidence-based Medicine. Voelker, Rebecca // JAMA: Journal of the American Medical Association;5/12/2015, Vol. 313 Issue 18, p1783 

    An interview with Gordon Guyatt, a physician and the principal editor of the book series "Users' Guides to the Medical Literature," is presented. When asked about a forthcoming edition of the series, he states that it covers advances in evidence-based medicine such as noninferiority trials. He...

  • Mini-symposium 4.  // Annals of Oncology;2016 Supplement, Vol. 27, pvii52 

    No abstract available.


Read the Article


Sign out of this library

Other Topics